Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Iradimed (IRMD) Shares Outstanding (2016 - 2026)

Iradimed has reported Shares Outstanding over the past 14 years, most recently at $12.8 million for Q1 2026.

  • Quarterly Shares Outstanding rose 0.53% to $12.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $12.8 million through Mar 2026, up 0.53% year-over-year, with the annual reading at $12.8 million for FY2025, 0.56% up from the prior year.
  • Shares Outstanding was $12.8 million for Q1 2026 at Iradimed, roughly flat from $12.8 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $12.8 million in Q1 2026 and troughed at $12.6 million in Q1 2022.
  • The 5-year median for Shares Outstanding is $12.7 million (2024), against an average of $12.7 million.
  • Year-over-year, Shares Outstanding grew 2.02% in 2022 and then increased 0.27% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $12.6 million in 2022, then rose by 0.55% to $12.7 million in 2023, then increased by 0.39% to $12.7 million in 2024, then rose by 0.56% to $12.8 million in 2025, then increased by 0.01% to $12.8 million in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Shares Outstanding are $12.8 million (Q1 2026), $12.8 million (Q4 2025), and $12.7 million (Q3 2025).